| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/14/1993 | EP0550807A2 Use of preparations of Curcuma plants |
| 07/14/1993 | EP0550779A1 Cosmetic and dermatologic composition containing diol diesters |
| 07/14/1993 | EP0550737A1 Controlled release verapamil tablet. |
| 07/14/1993 | EP0550716A1 Pharmaceutical compositions comprising hydroxamate derivatives for iron removal |
| 07/14/1993 | EP0550702A1 METHODS FOR PREPARATION AND USE OF 1$g(a),24-DIHYDROXY VITAMIN D 2? |
| 07/14/1993 | EP0550697A1 Pharmaceutical compositions containing functionalized vinylazoles, use of these vinylazoles for producing medicaments, these vinylazoles themselves and process for producing the same |
| 07/14/1993 | EP0550689A1 Ibuprofen-diuretic combinations |
| 07/14/1993 | EP0550668A1 Ibuprofen-antihistamine combinations |
| 07/14/1993 | EP0550595A1 Methods |
| 07/14/1993 | EP0550589A1 Substituted tricyclic compounds |
| 07/14/1993 | EP0550580A1 Uracil reductase inactivators |
| 07/14/1993 | EP0550576A1 Phenylpyridinol derivatives as medicaments |
| 07/14/1993 | EP0550574A1 Heterocyclic compounds |
| 07/14/1993 | EP0550570A1 Xanthine derivatives |
| 07/14/1993 | EP0550568A1 Anti-atherosclerotic aryl compounds |
| 07/14/1993 | EP0550566A1 Antiproliferative substituted naphthalene compounds |
| 07/14/1993 | EP0550559A1 Xanthines |
| 07/14/1993 | EP0550550A1 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
| 07/14/1993 | EP0550532A1 Dextrin sulfates as anti hiv-1 agents and composition thereof |
| 07/14/1993 | EP0550529A1 Pharmaceutical composition comprising cd4 and a polyanionic anti-hiv agent and use thereof |
| 07/14/1993 | EP0550518A1 1-substituted phenoxathiin derivatives as antidepressants |
| 07/14/1993 | EP0550507A1 Indole ureas as 5 ht receptor antagonist |
| 07/14/1993 | EP0550502A1 Substituted imidazoles, their preparation and pharmaceutical compositions |
| 07/14/1993 | EP0550478A1 Substituted 2 imidazolone derivatives, their preparation and pharmaceutical compositions |
| 07/14/1993 | EP0550464A1 Antiviral compounds and antihypertensive compounds |
| 07/14/1993 | EP0550446A1 Radioprotection by calcium antagonists |
| 07/14/1993 | EP0550444A1 Substituted naphthoxazines useful as dopaminergics |
| 07/14/1993 | EP0472645B1 Osmotic dosage form |
| 07/14/1993 | EP0443027B1 Drug composition |
| 07/14/1993 | EP0362321B1 Ophthalmic suspensions |
| 07/14/1993 | EP0334889B1 Composition for treating obesity |
| 07/14/1993 | CN1074218A Quinolone and naphthyridone-carboxylic acid derivatives |
| 07/14/1993 | CN1074214A Multilayer film materials system |
| 07/14/1993 | CN1074213A New derivative of tetrahydronaphthalene |
| 07/14/1993 | CN1074134A Medicinal granulating composite and its preparation method |
| 07/14/1993 | CN1074123A Process for the preparation of a pharmaceutical composition selectively lowering the blood lipid level |
| 07/14/1993 | CN1074118A Super-compact electric thermal treatment device |
| 07/14/1993 | CN1074116A Gum for brightening eyes |
| 07/14/1993 | CN1074115A Special granulating process for depressor pills (Jiangyaxin) |
| 07/14/1993 | CN1021575C Preparation method for ganglioside derivatives |
| 07/14/1993 | CN1021574C Preparing method for ganglioside derivatives |
| 07/14/1993 | CA2086987A1 Benzofuranyl- and thiophenylmethylthio-alkanecarboxylic acid derivatives |
| 07/13/1993 | USRE34313 Neutral 3:1 1-hydroxypyrid-2-one:iron /III/ complexes with specified substituents; treating patients with toxic iron concentrations by administering substituted hydroxypyridnes; use of complexes to increase blood iron levels |
| 07/13/1993 | US5227518 L-carnitine derivatives as therapeutical agents for treating myopathies and neuronal degeneration and for inhibiting proteolysis |
| 07/13/1993 | US5227496 Pyroglutamic acid derivatives as enhancers of learning processes and memory and pharmaceutical compositions comprising same |
| 07/13/1993 | US5227488 Aza spiro decane and use thereof in treating cns disorders |
| 07/13/1993 | US5227486 Reaction of spiro-quaternary ammonium compound |
| 07/13/1993 | US5227479 Process for the preparation of nojirimycin and related compounds |
| 07/13/1993 | US5227459 Synthetic melanin |
| 07/13/1993 | US5227404 Pharmaceutical composition for the treatment of glaucomatous optic neuropathy |
| 07/13/1993 | US5227401 Ethynyl alanine amino diol compounds for treatment of hypertension |
| 07/13/1993 | US5227400 Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them |
| 07/13/1993 | US5227395 1-Phenoxycarbonyl-2-pyrrolidones |
| 07/13/1993 | US5227394 Muscarinic cholinergic agonists, cognition activators, analgesics |
| 07/13/1993 | US5227393 α-fluoro-α-tetrazolyl-phenylmethyl derivatives useful as aromatase inhibitors |
| 07/13/1993 | US5227391 Nicotine compound |
| 07/13/1993 | US5227389 Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation |
| 07/13/1993 | US5227386 Indole derivatives |
| 07/13/1993 | US5227385 Method for treatment of neurodegenerative diseases |
| 07/13/1993 | US5227383 Sampangine analogs |
| 07/13/1993 | US5227378 Synergistic mixture of platelet activating factor and leukotriene antagonists |
| 07/13/1993 | US5227374 Sodium bicarbonate |
| 07/13/1993 | US5227373 Lyophilized ifosfamide compositions |
| 07/13/1993 | US5227371 Utilization of adenine nucleotides and/or adenosine and inorganic phosphate for elevation of liver, blood and blood plasma adenosine 5'-triphosphate concentrations |
| 07/13/1993 | US5227369 Carbohydrate blocking agent which inhibits LHR-mediated binding of leukocytes to myelin |
| 07/13/1993 | US5227157 Delivery of therapeutic agents |
| 07/13/1993 | CA1320310C 4-aminopyridine derivatives and their acid addition salts |
| 07/13/1993 | CA1320210C 3-(2-haloethyl)-1,4-oxathiins and 2-(2-haloethyl)-1, 4-dithiins and treatment of leukemia and tumors therewith |
| 07/13/1993 | CA1320207C Hemiphosphate hemihydrate of 2(2-pentyl-3-guanidino) -4-(2-methyl-4-imidazolyl)thiazole |
| 07/13/1993 | CA1320206C2 Halogen-substituted pyridines |
| 07/13/1993 | CA1320205C 1,4-dihydro-4-(nitro)phenyl-3,5-pyridinecarboxylates incorporating an alkylaminoalkylene-heteroatom group moiety on one of the carboxylate groups |
| 07/13/1993 | CA1320204C Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters |
| 07/13/1993 | CA1320203C2 Intermediates for 9-deazaguanines |
| 07/13/1993 | CA1320201C 4,5,6-substituted-2-pyrimidinamines |
| 07/13/1993 | CA1320199C Substituted imidazolyl-alkyl-piperazine and-diazepine derivatives |
| 07/13/1993 | CA1320198C Condensed diazepinones, processes for preparing them and pharmaceutical compositions containing these compounds |
| 07/13/1993 | CA1320197C Condensed diazepinones, processes for preparing them and pharmaceutical compositions containing these compounds |
| 07/13/1993 | CA1320196C Immunostimulating guanine derivatives, compositions and methods |
| 07/13/1993 | CA1320195C Adenosine derivatives |
| 07/13/1993 | CA1320194C Substituted pyrroles |
| 07/13/1993 | CA1320192C Pharmaceutical compositions |
| 07/13/1993 | CA1320134C Dissolved composition of [benzo-1,2,4-thiadiazine]-1, 1-dioxide |
| 07/13/1993 | CA1320133C Analgesic drug comprising l-tryptophan |
| 07/13/1993 | CA1320132C Dehydroepiandrosterone therapy |
| 07/13/1993 | CA1320131C Aqueous pharmaceutical preparation containing 11.beta.-hydroxy steroids |
| 07/13/1993 | CA1320128C Biostatic and biocidal compositions |
| 07/10/1993 | CA2086725A1 Sample processing using disinfectant |
| 07/09/1993 | CA2086689A1 Cosmetic or dermatological composition containing a diol ester |
| 07/08/1993 | WO1993013403A1 FLUORESCENCE DIAGNOSTICS OF CANCER USING δ-AMINO LEVULINIC ACID |
| 07/08/1993 | WO1993013197A1 Heme polymerase and method for treating malaria |
| 07/08/1993 | WO1993013138A1 A method for preparing enteric-coated oral drugs containing acid-unstable compounds |
| 07/08/1993 | WO1993013124A1 Inhibitors of 5-alpha-testosterone reductase |
| 07/08/1993 | WO1993013123A1 Novel 19-nor steroids having a thiocarbon-containing chain in the 11beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositions containing said steroids |
| 07/08/1993 | WO1993013121A1 Gapped 2' modified oligonucleotides |
| 07/08/1993 | WO1993013117A2 5- or 6-aminodeoxyfuranoside derivatives with antiinflammatory and antiproliferative activity |
| 07/08/1993 | WO1993013114A1 COMPOSITIONS AND METHODS FOR MODULATING β-AMYLOID |
| 07/08/1993 | WO1993013103A1 Imidazoquinazoline compounds and their preparation and use |
| 07/08/1993 | WO1993013099A1 ARYL KETONES AS TESTOSTERONE 5α-REDUCTASE INHIBITORS |
| 07/08/1993 | WO1993013097A1 Anti-rheumatic naphthyridine derivatives |
| 07/08/1993 | WO1993013096A1 Quinuclidine derivatives as squalene synthase inhibitors |